$FTEK
FUEL TECH, INC. Stock $ftek

$ftek Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013321 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$5.461M	$7.287M
YoY Change	-14.24%	31.65%
Cost Of Revenue	$3.465M	$4.482M
YoY Change	-6.1%	38.12%
Gross Profit	$1.996M	$2.805M
YoY Change	-25.47%	22.49%
Gross Profit Margin	36.55%	38.49%
Selling, General & Admin	$2.915M	$3.245M
YoY Change	1.43%	6.25%
% of Gross Profit	146.04%	115.69%
Research & Development	$413.0K	$218.0K
YoY Change	42.91%	-0.91%
% of Gross Profit	20.69%	7.77%
Depreciation & Amortization	$94.00K	$79.00K
YoY Change	-24.19%	-15.96%
% of Gross Profit	4.71%	2.82%
Operating Expenses	$3.328M	$3.463M
YoY Change	5.22%	5.77%
Operating Profit	-$1.332M	-$658.0K
YoY Change	174.64%	-33.13%
Interest Expense	$5.000K	$5.000K
YoY Change	25.0%	0.0%
% of Operating Profit
Other Income/Expense, Net	-$14.00K	-$90.00K
YoY Change	-110.45%	800.0%
Pretax Income	-$1.044M	-$414.0K
YoY Change	200.86%	-58.52%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.044M	-$414.0K
YoY Change	193.26%	-58.52%
Net Earnings / Revenue	-19.12%	-5.68%
Basic Earnings Per Share	-$0.03	-$0.01
Diluted Earnings Per Share	-$0.03	-$0.01
COMMON SHARES
Basic Shares Outstanding	30.30M	30.30M
Diluted Shares Outstanding	30.32M	30.30M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.99M	$26.77M
YoY Change	-10.6%	-21.68%
Cash & Equivalents	$15.13M	$15.70M
Short-Term Investments	$12.86M	$11.07M
Other Short-Term Assets	$1.287M	$1.350M
YoY Change	-54.78%	-36.5%
Inventory	$528.0K	$509.0K
Prepaid Expenses
Receivables	$6.781M	$6.755M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$36.59M	$35.38M
YoY Change	-10.73%	-14.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.368M	$4.370M
YoY Change	-4.13%	-4.04%
Goodwill	$2.116M	$2.116M
YoY Change	0.0%	0.0%
Intangibles	$382.0K	$401.0K
YoY Change	-8.17%	-10.49%
Long-Term Investments	$4.874M	$7.054M
YoY Change
Other Assets	$789.0K	$796.0K
YoY Change	-2.71%	-4.9%
Total Long-Term Assets	$13.02M	$14.90M
YoY Change	60.1%	82.52%
TOTAL ASSETS
Total Short-Term Assets	$36.59M	$35.38M
Total Long-Term Assets	$13.02M	$14.90M
Total Assets	$49.61M	$50.28M
YoY Change	1.0%	1.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.097M	$3.651M
YoY Change	31.9%	62.99%
Accrued Expenses	$1.091M	$1.097M
YoY Change	-1.18%	-10.08%
Deferred Revenue	$938.0K	$427.0K
YoY Change	62.28%	-18.2%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.126M	$5.175M
YoY Change	27.2%	29.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$280.0K	$277.0K
YoY Change	9.8%	2.97%
Total Long-Term Liabilities	$280.0K	$277.0K
YoY Change	9.8%	2.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.126M	$5.175M
Total Long-Term Liabilities	$280.0K	$277.0K
Total Liabilities	$5.959M	$5.680M
YoY Change	31.4%	26.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$117.4M	-$116.4M
YoY Change	1.33%	0.74%
Common Stock	$165.0M	$164.8M
YoY Change	0.25%	0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.65M	$44.60M
YoY Change
Total Liabilities & Shareholders Equity	$49.61M	$50.28M
YoY Change	1.0%	1.33%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.044M	-$414.0K
YoY Change	193.26%	-58.52%
Depreciation, Depletion And Amortization	$94.00K	$79.00K
YoY Change	-24.19%	-15.96%
Cash From Operating Activities	-$993.0K	$1.010M
YoY Change	-36.95%	-157.85%
INVESTING ACTIVITIES
Capital Expenditures	$73.00K	$30.00K
YoY Change	-185.88%	-156.6%
Acquisitions
YoY Change
Other Investing Activities	$500.0K	-$8.685M
YoY Change
Cash From Investing Activities	$427.0K	-$8.715M
YoY Change	-602.35%	16343.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	42.00K	$0.00
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-993.0K	$1.010M
Cash From Investing Activities	427.0K	-$8.715M
Cash From Financing Activities	42.00K	$0.00
Net Change In Cash	-524.0K	-$7.630M
YoY Change	-68.43%	320.62%
FREE CASH FLOW
Cash From Operating Activities	-$993.0K	$1.010M
Capital Expenditures	$73.00K	$30.00K
Free Cash Flow	-$1.066M	$980.0K
YoY Change	-28.46%	-157.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15698000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23328000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	11067000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18646000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18557000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	418000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	406000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31272303
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31272303
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30296297
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30296297
CY2022Q4	ftek	Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts	0	pure
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	976006
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2251000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	159000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33059
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5657551
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	27601 Bella Vista Parkway
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Warrenville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60555-1617
CY2023Q1	dei	City Area Code CityAreaCode	630
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	845-4500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	FTEK
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2981000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6755000	usd
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7729000	usd
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30296297
CY2023Q1	us-gaap	Inventory Net InventoryNet	509000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	392000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1350000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1395000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	35379000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	35825000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4370000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4435000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2116000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2116000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	401000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	397000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	7054000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	6360000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	796000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	794000	usd
CY2023Q1	us-gaap	Assets Assets	50282000	usd
CY2022Q4	us-gaap	Assets Assets	50124000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3651000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2710000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	109000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	588000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1105000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	827000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	826000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5175000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4766000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	66000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	177000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	177000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	277000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	274000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5680000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5283000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	313000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	313000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	164511000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	164422000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116405000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115991000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1642000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1728000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	76000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	76000	usd
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2251000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2251000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	44602000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	44841000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50282000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50124000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	4482000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3245000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3245000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3054000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	218000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	7945000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	6519000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-658000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-984000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	5000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	5000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	339000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-414000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-998000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-414000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-998000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30296000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30267000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30296000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30267000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-414000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-998000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-70000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-328000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1068000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	46200000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-998000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-70000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45133000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	44841000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-414000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	89000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	44602000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-414000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-998000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	79000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	94000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	11000	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	95000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	-0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-25000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	89000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-990000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1520000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	116000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	934000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	682000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-519000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1010000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1746000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	30000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	53000	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	9685000	usd
CY2022Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	1000000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8715000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	-0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	17000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7630000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1814000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23328000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37054000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15698000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35240000	usd
CY2023Q1	ftek	Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	5535000	usd
CY2023Q1	ftek	Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Two Through Three DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree	1447000	usd
CY2023Q1	ftek	Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year Two Through Three DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree	1426000	usd
CY2023Q1	us-gaap	Cash Cash	13505000	usd
CY2022Q1	us-gaap	Cash Cash	34174000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2193000	usd
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1066000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15698000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35240000	usd
CY2022Q4	ftek	Investment Plan Maximum Amount Approved InvestmentPlanMaximumAmountApproved	20000000	usd
CY2023Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	18121000	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	9341000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	148000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	168000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	17973000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	9173000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	11067000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	11012000	usd
CY2023Q1	ftek	Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	5607000	usd
CY2023Q1	us-gaap	Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	18121000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	17973000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	223000	usd
CY2022	ftek	Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange	-19000	usd
CY2022	ftek	Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries	94000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	110000	usd
CY2023Q1	ftek	Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange	0	usd
CY2023Q1	ftek	Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries	-0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	110000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	427000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	372000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	390000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	359000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	230000	usd
CY2023Q1	ftek	Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts	0	pure
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7588000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7277000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3295000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4605000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	3444000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	3082000	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	126000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	152000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	110000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	110000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6755000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7729000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	976006
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2251000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30296000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30267000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30296000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30267000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	384500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.98
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	384500
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.98
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M8D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	384500
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.98
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y2M8D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	28000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2850000
CY2022Q2	ftek	Percentage Of Face Amount Of Letters Of Credit As Collateral PercentageOfFaceAmountOfLettersOfCreditAsCollateral	1.50	pure
CY2022Q2	ftek	Payment Basis Points On Face Value Of Letters Of Credit PaymentBasisPointsOnFaceValueOfLettersOfCredit	0.0250	pure
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1281000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	4482000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2805000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3245000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	218000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-658000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3245000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2290000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3054000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-984000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7287000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5535000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	50282000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	50124000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	427000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	372000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	159000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	159000	usd
CY2023Q1	ftek	Other Accrued Liabilities Miscellaneous Current OtherAccruedLiabilitiesMiscellaneousCurrent	241000	usd
CY2022Q4	ftek	Other Accrued Liabilities Miscellaneous Current OtherAccruedLiabilitiesMiscellaneousCurrent	295000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	827000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	826000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	159000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd

Files In Submission

Name	View Source	Status
ftek-20230331_lab.xml	Edgar Link	unprocessable
0001437749-23-013321-index-headers.html	Edgar Link	pending
0001437749-23-013321-index.html	Edgar Link	pending
0001437749-23-013321.txt	Edgar Link	pending
0001437749-23-013321-xbrl.zip	Edgar Link	pending
ex_462688.htm	Edgar Link	pending
ex_462689.htm	Edgar Link	pending
ex_462690.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ftek-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ftek-20230331_cal.xml	Edgar Link	unprocessable
ftek-20230331_def.xml	Edgar Link	unprocessable
ftek20230331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
ftek-20230331_pre.xml	Edgar Link	unprocessable
ftek20230331_10q_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FTEK
FUEL TECH, INC. Stock $ftek

2023 Q2 Form 10-Q Financial Statement

#000143774923013321 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTEK FUEL TECH, INC. Stock $ftek

2023 Q2 Form 10-Q Financial Statement

#000143774923013321 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTEK
FUEL TECH, INC. Stock $ftek